Dr. Ward has spent the past 16 years developing mouse models to help identify the cellular and molecular mechanisms underlying inflammatory skin disease and its associated comorbidities, including atherothrombosis, psoriatic arthritis, inflammatory bowel disease, and depression. Read this article to see what Dr. Ward is currently investigating. Read now
This report provides a meeting summary and key points of presentations and discussions held during IPC's 2020 virtual Think Tank. Read now
This report provides a meeting summary and key points of presentations and discussions held during IPC's 2019 Think Tank. Read now
This report provides a meeting summary and key points of presentations and discussions held during IPC's 2018 Think Tank. Download
The IPC contributed to the the WHO Global Report on Psoriasis (2016) and subsequently launched the Global Psoriasis Atlas project in April 2017. Download
now available COVID-19 Psoriasis Resource Center Information from around the world on psoriasis and coronavirus to assist dermatologists and the patients they serve explore now
Information from around the world on psoriasis and coronavirus to assist dermatologists and the patients they serve
Latest news PsoProtect Registry Data UpdateSeptember 13, 2021Update on the PsoProtect Registry. PsoProtect is a global registry for clinicians to report outcomes of COVID-19 in individuals with psoriasis. Data set currently includes 1,205 cases. July Update on PsoProtect Registry DataJuly 12, 2021Update on the PsoProtect Registry. PsoProtect is a global registry for clinicians to report outcomes of COVID-19 in individuals with psoriasis. Data set currently includes 1,147 cases. Expert Opinion: Coronavirus disease 2019 (COVID‐19)‐associated hospitalization and mortality in patients with psoriasis: A population‐based studyJuly 07, 2021IPC Councilor, Luigi Naldi, MD, shares his expert opinion on a population-based study of COVID-19 - associated hospitalization and mortality in patients with psoriasis. Grand Rounds tutorial on IPC's psoriasis severity reclassificationJune 21, 2021The AbbVie program features IPC Board Member Bruce Strober’s Grand Rounds, a tutorial explaining the current method of measuring the severity of psoriasis, why this limits proper care and treatment for psoriasis patients, how IPC’s Disease Severity Reclassification Project solves these problems, and how clinicians can implement this new classification method. More News